Medigap Eligibility and Enrollment

Medigap, also known as Medicare Supplement insurance, is private health insurance designed to supplement original Medicare. It helps pay for some of the out-of-pocket costs that Medicare does not cover, such as deductibles, copayments, and coinsurance. Here are the key features of Medigap eligibility and enrollment:

• Eligibility: To be eligible for Medigap, you must be enrolled in both Medicare Part A and Part B. You can apply for Medigap if you are age 65 or older or have a qualifying disability.

• Enrollment period: The best time to enroll in Medigap is during your six-month Medigap Open Enrollment Period, which starts on the first day of the month in which you are both 65 or older and enrolled in Medicare Part B. During this period, insurance companies cannot deny you coverage or charge you higher premiums based on your health status.

• Guaranteed issue rights: You may have guaranteed issue rights to enroll in a Medigap plan outside of your Medigap Open Enrollment Period if you have certain qualifying events, such as losing employer health coverage or moving out of your plan's service area.

• Plan options: Medigap plans are standardized and identified by letters A, B, C, D, F, G, K, L, M, and N. Each plan offers a different set of benefits. For example, Plan F is the most comprehensive and covers all of the out-of-pocket costs that Medicare does not cover.

• Cost: Medigap premiums vary depending on the plan you choose, your age, your location, and other factors. Generally, Medigap plans with more comprehensive coverage have higher premiums.

Example:

Let's say you are 67 years old and enrolled in Medicare Parts A and B. You have decided to enroll in a Medigap plan to help pay for your out-of-pocket costs.

During your Medigap Open Enrollment Period, you apply for Plan F, which is the most comprehensive Medigap plan. The insurance company cannot deny you coverage or charge you higher premiums based on your health status.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.